This article is available online at http://www.jlr.org S1P recruits lymphocytes from the thymus and secondary lymphoid organs to the circulatory system by activating S1P receptors on lymphocytes (5). Many components of blood, such as erythrocytes, platelets, and neutrophils, express sphingosine kinases and produce S1P (6). Platelets contain large amounts of S1P and release it only when activated by stimuli, such as thrombin, whereas erythrocytes constitutively release S1P in the absence of stimuli. Because erythrocytes constitute a large proportion of the blood cells in the body and because they lack S1P-degrading activity catalyzed by S1P lyase (SGPL1), S1P phosphatases (SGPP1 and SGPP2), and phospholipid phosphatases (PLPP1, PLPP2, and PLPP3) (7), they contribute substantially to plasma S1P. In addition to blood cells, endothelial cells constitutively release S1P into the blood without stimuli (8). Thus, plasma S1P is derived mainly from erythrocytes and endothelial cells (9). When the S1P supply from erythrocytes has been disrupted, the plasma S1P level and the number of the lymphocytes in the blood decrease substantially (10). Therefore, plasma S1P supplied by erythrocytes is essential for the correct distribution of lymphocytes in the blood.Erythrocytes transport sphingosine, which is supplied by other cells, to the intracellular side of the membrane and produce S1P by phosphorylation (6,7,11). In addition to the extracellular source of sphingosine, intracellular alkaline ceramidase also produces sphingosine used for S1P synthesis in human erythrocytes (12). Previously, we reported that erythrocytes export intracellularly synthesized S1P into the extracellular space via an ATP-dependent transporter in a time-dependent manner without any Abstract Sphingosine-1-phosphate (S1P) is present in the blood plasma and acts as a pivotal intercellular signal transmitter in the immune system by recruiting lymphocytes from the thymus and secondary lymphoid tissues. The plasma S1P concentration is maintained by the supply of S1P from erythrocytes. Previously, we showed that S1P release from erythrocytes is mediated by an ATP-dependent transporter. In this study, we attempted to establish a rapid and reliable method for measuring the S1P transport activity in erythrocytes by using a fluorescent S1P analog, 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD)-labeled S1P. NBD-S1P was released from erythrocytes in a time-dependent manner. The NBD-S1P release was reduced after exposure to glyburide, which is an inhibitor of the S1P transporter in erythrocytes. Moreover, the release of NBD-S1P and S1P from erythrocytes was competitively inhibited by intracellular S1P and NBD-S1P, respectively. These results showed that the erythrocyte S1P transporter exports NBD-S1P. We optimized the sample-preparation conditions and lipid extraction to increase the sensitivity of the assay. Furthermore, we successfully measured NBD-S1P release without lipid extraction by decreasing the concentration of BSA in the assay buffer to 0.1%. This method will be ...